Literature DB >> 33783747

Therapeutic Potential of Astaxanthin in Diabetic Kidney Disease.

Yuji Naito1, Kazuhiko Uchiyama2, Osamu Handa3, Wataru Aoi4.   

Abstract

Astaxanthin is a carotenoid that has potent protective effects on diabetic kidney disease (DKD) in diabetic mice models. DNA microarray study clearly demonstrated the involvement of mitochondrial oxidative phosphorylation pathway in the renal glomerular cells of diabetic mice and also showed that the expression of upregulated genes associated with this pathway was decreased by the treatment with astaxanthin. Proteomic analysis confirmed that the increases of 4-hydroxy-2-nonenal (HNE)- and Nε-(hexanonyl)lysine (HEL)-modified proteins were inhibited by the treatment with astaxanthin. These results demonstrated that astaxanthin exerts a protective effect against hyperglycemia-induced DKD by attenuating mitochondrial oxidative stress and subsequent cellular dysfunction.

Entities:  

Keywords:  4-Hydroxy-2-nonenal; Diabetic kidney disease; Glomerular cell; Mitochondrial oxidative phosphorylation

Mesh:

Substances:

Year:  2021        PMID: 33783747     DOI: 10.1007/978-981-15-7360-6_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Microarray profiling of gene expression patterns in glomerular cells of astaxanthin-treated diabetic mice: a nutrigenomic approach.

Authors:  Yuji Naito; Kazuhiko Uchiyama; Katsura Mizushima; Masaaki Kuroda; Satomi Akagiri; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Norimasa Yoshida; Hiroshi Ichikawa; Jiro Takahashi; Toshikazu Yoshikawa
Journal:  Int J Mol Med       Date:  2006-10       Impact factor: 4.101

2.  Dietary beta-carotene and astaxanthin but not canthaxanthin stimulate splenocyte function in mice.

Authors:  B P Chew; M W Wong; J S Park; T S Wong
Journal:  Anticancer Res       Date:  1999 Nov-Dec       Impact factor: 2.480

3.  Astaxanthin improves cognitive deficits from oxidative stress, nitric oxide synthase and inflammation through upregulation of PI3K/Akt in diabetes rat.

Authors:  Lianbao Xu; Juan Zhu; Weibing Yin; Xinsheng Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
  3 in total
  1 in total

1.  Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.

Authors:  Fenghui Pan; Wenxia Cui; Lei Gao; Xiaoting Shi; Haiyan Yang; Yun Hu; Man Li
Journal:  J Clin Lab Anal       Date:  2022-03-15       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.